We Will Cure

The newly released Cure Innovation Index reveals which U.S. research institutions actually turn biomedical science into patient impact.

Of the select 303 institutions on the list, there are some that are outperforming their federal funding by a lot, in some cases by 100+ spots. They’re doing more with less. Better support for founders, closer industry ties, more intentional commercialization.

See the list of 20 overperforming universities here: wewillcure.com/insights/innov…

The conditions that turn science into cures have never been measured systematically — until now. The Cure Innovation Index benchmarks what drives success in the top 303 U.S. institutions. #CureInnovationIndex, via @EurekAlert! eurekalert.org/news-releases/…

🚨New Cure survey of 100+ healthcare CEOs + founders reveals:
87% remain optimistic about the future of biotech—despite funding dips + policy shifts.
📈 65% say access to capital is their top concern.
🔗 Read the full report: wewillcure.com/insights/healt… #Biotech #policyshifts #FutureOfHealth #HealthcareInnovation #Funding

This morning, @xprize Executive Director, @j_n_justice and Cure CEO Seema Kumar kicked off the XPRIZE Healthspan Investor Summit.
The event features semifinalist teams from the $101M XPRIZE Healthspan competition, 40 innovative organizations from around the globe, and leading investors in healthspan and longevity. The Summit provides opportunities for business leaders to get early access to groundbreaking investment opportunities presented by visionary innovators. #XPRIZEhealthspan #longevity #healthspan #investors

@Congratulations Dr. Randi Silver.